Also tagged in: Administrative procedure, Apartment houses, Child safety, Children, Congress, Congressional reporting requirements, Department of Housing and Urban Development, Environmental protection, Executive departments, Hazardous substances, Housing, Housing subsidies, Law, Lead, Lead poisoning, Medical care, Medicine, Paints and varnishes, Residential rehabilitation
Latest Action: 09/26/2008 - Read twice and referred to the Committee on Banking, Housing, and Urban Affairs. Bill TextA bill to amend the Residential Lead-Based Paint Hazard Reduction Act of 1992 to define environmental intervention blood lead level, and for other purposes. 9/26/2008--Introduced. Lead-Safe Housing for Kids Act of 2008 - Amends the Residential Lead-Based Paint Hazard Reduction Act of 1992, with respect to lead-based paint hazards in housing, to set the environmental intervention blood lead level as equal to the lower of: (1) ten micrograms of lead per deciliter; or (2) the elevated blood lead level of concern for a child under six years of age recommended by the Centers for Disease Control and Prevention. Requires the Secretary of Housing and Urban Development to amend related regulations to comply with this Act within 90 days. Requires the Secretary to report to Congress on the status of the Department of Housing and Urban Development "Big Buy" program, and any other voluntary programs the Secretary has implemented or has planned to implement, through [...] show full description
Also tagged in: Bioaccumulation, Business, Business records, Chemical industries, Chemistry, Child health, Child safety, Children, Consumer education, Consumer goods, Consumers, Data banks, Environmental health, Environmental protection, Executive departments, Federal advisory bodies, Foreign policy, Government information, Government paperwork, Government publicity, Hazardous substances, Health surveys, Hormones, Immune system, Import restrictions, International affairs, International cooperation, Medical care, Medical tests, Medicine, Product safety, Standards, Technology, Toxicology, Trade
Latest Action: 05/20/2008 - Read twice and referred to the Committee on Environment and Public Works. Bill TextA bill to amend the Toxic Substances Control Act to reduce the exposure of children, workers, and consumers to toxic chemical substances. 5/20/2008--Introduced. Kid-Safe Chemicals Act of 2008 - Amends the Toxic Substances Control Act to require each manufacturer of a chemical substance distributed in commerce to submit to the Administrator of the Environmental Protection Agency (EPA): (1) a statement certifying that the substance meets required safety standards or that there is insufficient data to make such determination; and (2) all reasonably available information concerning the substance not previously submitted. Requires manufacturers to update such information at least every three years or at any time new information becomes available on a substance's toxicity. Requires manufacturers to provide chemical safety information upon the Administrator's request.Prohibits the manufacture, importation, or distribution in commerce of a chemical substance if the Administrator [...] show full description
Also tagged in: Bioaccumulation, Business, Business records, Chemical industries, Chemistry, Child health, Child safety, Children, Consumer education, Consumer goods, Consumers, Data banks, Environmental health, Environmental protection, Executive departments, Federal advisory bodies, Foreign policy, Government information, Government paperwork, Government publicity, Hazardous substances, Health surveys, Hormones, Immune system, Import restrictions, International affairs, International cooperation, Medical care, Medical tests, Medicine, Product safety, Standards, Technology, Toxicology, Trade
Latest Action: 05/21/2008 - Referred to the Subcommittee on Environment and Hazardous Materials. Bill TextTo amend the Toxic Substances Control Act to reduce the exposure of children, workers, and consumers to toxic chemical substances. 5/20/2008--Introduced. Kid-Safe Chemicals Act of 2008 - Amends the Toxic Substances Control Act to require each manufacturer of a chemical substance distributed in commerce to submit to the Administrator of the Environmental Protection Agency (EPA): (1) a statement certifying that the substance meets required safety standards or that there is insufficient data to make such determination; and (2) all reasonably available information concerning the substance not previously submitted. Requires manufacturers to update such information at least every three years or at any time new information becomes available on a substance's toxicity. Requires manufacturers to provide chemical safety information upon the Administrator's request.Prohibits the manufacture, importation, or distribution in commerce of a chemical substance if the Administrator [...] show full description
Also tagged in: Administrative procedure, Aged, Cancer, Congress, Congressional veto, Department of Health and Human Services, Executive departments, Health policy, Law, Medical care, Medicare, Medicine
Latest Action: 10/22/2007 - Sponsor introductory remarks on measure. (CR S13200-13201) Bill TextA joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services within the Department of Health and Human Services relating to Medicare coverage for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions. 10/22/2007--Introduced. Disapproves a specified rule submitted by the Centers for Medicare & Medicaid Services of the Department of Health and Human Services relating to Medicare coverage for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions. Declares that such rule shall have no force or effect.
Also tagged in: Administrative procedure, Aged, Cancer, Congress, Congressional veto, Department of Health and Human Services, Executive departments, Health policy, Law, Medical care, Medicare, Medicine
Latest Action: 11/08/2007 - Referred to the Subcommittee on Health. Bill TextProviding for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services within the Department of Health and Human Services relating to Medicare coverage for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions. 9/27/2007--Introduced. Disapproves a specified rule submitted by the Centers for Medicare & Medicaid Services of the Department of Health and Human Services relating to Medicare coverage for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions. Declares that such rule shall have no force or effect.
Latest Action: 09/04/2007 - Senate Committee on Finance discharged by Unanimous Consent. (consideration: CR S11080-11081) Bill TextA resolution to express the sense of the Senate regarding the Medicare national coverage determination on the treatment of anemia in cancer patients. 9/4/2007--Passed Senate without amendment. (There is 1 other summary) (This measure has not been amended since it was introduced. The summary of that version is repeated here.) Expresses the sense of the Senate that the Centers for Medicare & Medicaid Services should: (1) begin an immediate reconsideration of the final National Coverage Determination on the Use of Erythropoiesis Stimulating Agents in Cancer and Related Neoplastic Conditions (CAG-000383N); (2) consult with members of the clinical oncology community to determine appropriate revisions to it: and (3) implement such revisions as soon as feasible, and brief Congress in advance of announcing such changes.
Also tagged in: Administrative procedure, Child safety, Children, Department of Housing and Urban Development, Environmental protection, Executive departments, Hazardous substances, Housing, Law, Lead, Lead poisoning, Medical care, Medicine, Paints and varnishes, Residential rehabilitation
Latest Action: 05/14/2008 - Subcommittee Consideration and Mark-up Session Held. Bill TextTo amend the Residential Lead-Based Paint Hazard Reduction Act of 1992 to define environmental intervention blood lead level. 8/3/2007--Introduced. Lead-Safe Housing for Kids Act of 2007 - Amends the Residential Lead-Based Paint Hazard Reduction Act of 1992 to set the environmental intervention blood lead level for a confirmed concentration of lead in whole blood as equal to or greater than ten micrograms of lead per deciliter for a single test, for purposes of provisions concerning lead-based paint hazards in housing. Requires the Secretary of Housing and Urban Development to amend relevant regulations to comply with this Act within 90 days.
Also tagged in: Accident insurance, Actions and defenses, Bribery, Business, Child health, Children, Collection of accounts, Conflict of interests, Consumers, Criminal justice, Damages, Department of Health and Human Services, Disability insurance, Disabled, Drug approvals, Drug industry, Drugs, Evidence (Law), Executive departments, Federal officials, Federal preemption, Finance, Fines (Penalties), Fraud, Government employees, Health care fraud, Health insurance, Health policy, Labeling, Labor, Law, Legal fees, Liability (Law), Liability insurance, Licenses, Liens, Limitation of actions, Medical care, Medical instruments and apparatus, Medical malpractice, Medical supplies, Medicine, Minors, Misconduct in office, Packaging, Parties to actions, Politics and government, Product safety, Products liability, Punitive damages, State and local government, State laws, Vaccines, Workers' compensation
Latest Action: 06/06/2007 - Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the commit Bill TextTo improve patient access to health care services and provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system. 6/6/2007--Introduced. Help Efficient, Accessible, Low Cost, Timely Healthcare (HEALTH) Act of 2007 - Sets conditions for lawsuits arising from health care liability claims regarding health care goods or services or any medical product affecting interstate commerce. Sets a statute of limitations of three years after the date of manifestation of injury or one year after the claimant discovers the injury, with certain exceptions. Provides that nothing in this Act limits recovery of the full amount of available economic damages. Limits noneconomic damages to $250,000. Makes each party liable only for the amount of damages directly proportional to such party's percentage of responsibility. Allows the court to restrict the payment of attorney contingency fees. Limits the fees to a decreasing [...] show full description
Latest Action: 01/04/2007 - Referred to the House Committee on Ways and Means. Bill TextTo amend the Internal Revenue Code of 1986 to allow a credit against tax for expenses related to the collection and storage of umbilical cord blood. 1/4/2007--Introduced. Amends the Internal Revenue Code to allow a tax credit for 50% of qualified umbilical cord blood collection and storage expenses, up to $2,000 in a taxable year. Defines "qualified umbilical cord blood collection and storage expenses" as expenses directly related to the collection, storage, and maintenance of umbilical cord blood collected at the birth of a child.
|
Bill Categories in Federal Government
|
